Despite progress in data transparency, the FDA still keeps its data secret

By Maryanne Demasi, PhD | November 10, 2022 History shows that hiding clinical trial data can be deadly. Vioxx is a well-known example of how the US drug regulator withheld important information about the harms of the drug for over three years, before it was withdrawn from the market and tens of thousands of people died as […]

Source